Blood tests could pave the way for distinguishing between Alzheimer’s, Parkinson’s and some dementias, aiding early treatment for brain diseases.

C-reactive protein (CRP), an acute phase reactant and a strong marker of inflammation, has been found repeatedly to be a strong predictor of future cardiovascular events1 and a marker of statin ...

Background: Although C-reactive protein (CRP) levels are increased in chronic obstructive pulmonary disease (COPD), it is not certain whether they are associated with adverse clinical outcomes.

Background and Purpose— Complement components are emerging risk factors for cardiovascular disease. In this study, we examined the relation among C3, C-reactive protein (CRP), factor B, and features ...

Background: The ratio of C-reactive protein to high-density lipoprotein cholesterol (CRP/HDL-c) reflects systemic inflammation and lipid status, both of which are implicated in uric acid metabolism.

The suitability of silicon electrodes coated with thermally grown silicon dioxide film as disposable working electrodes in sensitive time-resolved ECL measurements is demonstrated, and a rapid ...

C-reactive protein has long been recognized as an innate opsonin, that is, a protein that recognizes microbes and promotes their uptake by phagocytic cells.

Abstract C-reactive protein (CRP), the prototypic acute-phase protein, increases rapidly in response to infection and inflammation.

Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000; 102: 2165–2168. Crossref Medline Google Scholar 17 Pasceri V, Chang J, Willerson JT, et al.

Objective To explore clinicians views of the barriers and facilitators to use of C-reactive protein (CRP) point-of-care tests (POCT) in US family medicine clinics for the management of acute ...